Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery
Inotiv, Inc. (NOTV)
Company Research
Source: GlobeNewswire
WEST LAFAYETTE, Ind., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced a strategic initiative to leverage LifeNet Health’s proprietary TruVivo® within its Discovery and Translational Sciences business. LifeNet Health, a global leader in regenerative medicine, has developed the patented TruVivo® system, which uses primary human hepatocytes cultured with human-derived feeder cells to create physiologically relevant in vitro models. This technology provides a stronger foundation for predicting human responses to new therapies and addresses a critical challenge in drug development. “Translational science is about connecting basic research to patient outcomes,” said Scott Daniels, PhD, Senior Vice President of Discovery & Translational Sciences (DTS) a
Show less
Read more
Impact Snapshot
Event Time:
NOTV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NOTV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NOTV alerts
High impacting Inotiv, Inc. news events
Weekly update
A roundup of the hottest topics
NOTV
News
- Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities [Yahoo! Finance]Yahoo! Finance
- Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics CapabilitiesGlobeNewswire
- Inotiv Inc (NOTV) Q4 2025 Earnings Call Highlights: Revenue Growth Amid Cybersecurity Challenges [Yahoo! Finance]Yahoo! Finance
- Inotiv (NASDAQ:NOTV) had its "buy" rating reaffirmed by analysts at Lake Street Capital.MarketBeat
- Inotiv, Inc. (NOTV) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
NOTV
Earnings
- 8/6/25 - Miss
NOTV
Sec Filings
- 1/16/26 - Form 8-K
- 1/16/26 - Form 4
- 1/7/26 - Form 8-K
- NOTV's page on the SEC website